Relationships between the physicochemical properties of an amphiphilic triblock copolymers/DNA complexes and their intramuscular transfection efficiency

被引:34
作者
Bello-Roufai, Mahajoub [1 ]
Lambert, Olivier
Pitard, Bruno
机构
[1] INSERM, Inst Thorax, U533, Fac Med, F-44000 Nantes, France
[2] Univ Bordeaux 1, CNRS, UMR 5471, IECB UBS, F-33405 Talence, France
关键词
D O I
10.1093/nar/gkl860
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Poly(ethyleneoxide)-poly(propyleneoxide)-poly(ethyleneoxide) triblock copolymer (PEO-PPO-PEO) based plasmid delivery systems are increasingly drawing attention in the field of nonviral gene transfer because of their proven in vivo transfection capability. They result from the simple association of DNA molecules with uncharged polymers. We examined the physicochemical properties of PEO-PPO-PEO/DNA mixtures, in which the PEO-PPO-PEO is Lutrol (R) (PEO75-PPO30-PEO75), formulated under various conditions. We found that interactions between PEO-PPO-PEO and DNA are mediated by the central hydrophobic block within the block copolymer. Dynamic light scattering and cryo-electron microscopy showed that the mean diameter of transfecting particles as well as their stability depended on the PEO-PPO-PEO/DNA ratio and on the ionic composition of the formulating medium. The most active formulation promoting a good tissue-distribution and an optimal transfection was characterized by a reduced electrophoretic mobility, a mean hydrodynamic diameter of similar to 250-300 nm and by a conserved B-DNA form as shown by circular dichroism studies. Our study also revealed that the stability of these formulations strongly depended on a concentration balance between the DNA and the PEO-PPO-PEO, over which the DNA conformation was modified, micron-sized particles were generated, and the transgene expression was declined. We showed that the physicochemical properties of PEO-PPO-PEO/DNA formulations directly impact the level of gene expression in transfected muscles.
引用
收藏
页码:728 / 739
页数:12
相关论文
共 42 条
[1]   Conformational change in DNA induced by cationic bilayer membranes [J].
Akao, T ;
Fukumoto, A ;
Ihara, H ;
Ito, A .
FEBS LETTERS, 1996, 391 (1-2) :215-218
[2]   Poly(ethylene oxide) poly(propylene oxide) block copolymer surfactants [J].
Alexandridis, P .
CURRENT OPINION IN COLLOID & INTERFACE SCIENCE, 1997, 2 (05) :478-489
[3]   Lyotropic liquid crystallinity in amphiphilic block copolymers: Temperature effects on phase behavior and structure for poly(ethylene oxide)-b-poly(propylene oxide)-b-poly(ethylene oxide) copolymers of different composition [J].
Alexandridis, P ;
Zhou, DL ;
Khan, A .
LANGMUIR, 1996, 12 (11) :2690-2700
[4]   Optimal structure requirements for pluronic block copolymers in modifying P-glycoprotein drug efflux transporter activity in bovine brain microvessel endothelial cells [J].
Batrakova, EV ;
Li, S ;
Alakhov, VY ;
Miller, DW ;
Kabanov, AV .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 304 (02) :845-854
[5]   Evidence for three-dimensional interlayer correlations in cationic lipid-DNA complexes as observed by cryo-electron microscopy [J].
Battersby, BJ ;
Grimm, R ;
Huebner, S ;
Cevc, G .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1998, 1372 (02) :379-383
[6]   The structure of DNA within cationic lipid/DNA complexes [J].
Braun, CS ;
Jas, GS ;
Choosakoonkriang, S ;
Koe, GS ;
Smith, JG ;
Middaugh, CR .
BIOPHYSICAL JOURNAL, 2003, 84 (02) :1114-1123
[7]   Gene therapy for SCID - a complication after remarkable progress [J].
Buckley, RH .
LANCET, 2002, 360 (9341) :1185-1186
[8]   Non-Viral Vector as Vaccine Carrier [J].
Chen, Weihsu Claire ;
Huang, Leaf .
NON-VIRAL VECTORS FOR GENE THERAPY, SECOND EDITION: PART 2, 2005, 54 :315-337
[9]   Characterization of a targeted gene carrier, lactose-polyethylene glycol-grafted poly-L-lysine, and its complex with plasmid DNA [J].
Choi, YH ;
Liu, F ;
Choi, JS ;
Kim, SW ;
Park, JS .
HUMAN GENE THERAPY, 1999, 10 (16) :2657-2665
[10]   Nonionic amphiphilic block copolymers promote gene transfer to the lung [J].
Desigaux, L ;
Gourden, C ;
Roufaï, MB ;
Richard, P ;
Oudrhiri, N ;
Lehn, P ;
Escande, D ;
Pollard, H ;
Pitard, B .
HUMAN GENE THERAPY, 2005, 16 (07) :821-829